RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF
申请人:The Johns Hopkins University
公开号:US20210094933A1
公开(公告)日:2021-04-01
The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
At every turn: Electron paramagnetic resonance spectroscopy was used to investigate the dynamics of triple helix folding/unfolding of host–guest collagen mimetic peptide with a spin‐labeled central triplet in Ac‐(Gly‐Pro‐Hyp)7‐Gly‐Gly‐NH2 (see figure).
Rapafucin derivative compounds and methods of use thereof
申请人:The Johns Hopkins University
公开号:US11066416B2
公开(公告)日:2021-07-20
The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
[EN] MELANOCORTIN RECEPTOR AGONISTS<br/>[FR] AGONISTES DU RÉCEPTEUR DE LA MÉLANOCORTINE
申请人:LG LIFE SCIENCES LTD
公开号:WO2008007930A1
公开(公告)日:2008-01-17
[EN] The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient. [FR] L'invention porte sur un composé de la formule (1) suivante, sur un sel et un isomère pharmaceutiquement acceptables de ce dernier, qui sont efficaces comme agonistes du récepteur de la mélanocortine, et sur une composition agoniste du récepteur de la mélanocortine renfermant ces derniers comme principe actif.